Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

 64.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 64.60p
  • 52 Week Low: 29.35p
  • Currency: UK Pounds
  • Shares Issued: 540.57m
  • Volume: 126,403
  • Market Cap: £348.66m
  • RiskGrade: 119
  • Beta: 0.01

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
24.93% below the market average24.93% below the market average24.93% below the market average24.93% below the market average24.93% below the market average
40% below the sector average40% below the sector average40% below the sector average40% below the sector average40% below the sector average
1yr Revenue Growth
27.63% below the market average27.63% below the market average27.63% below the market average27.63% below the market average27.63% below the market average
41.94% below the sector average41.94% below the sector average41.94% below the sector average41.94% below the sector average41.94% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
4.79% below the market average4.79% below the market average4.79% below the market average4.79% below the market average4.79% below the market average
42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average
Price Book Ratio
37.73% below the market average37.73% below the market average37.73% below the market average37.73% below the market average37.73% below the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
33.51% above the market average33.51% above the market average33.51% above the market average33.51% above the market average33.51% above the market average
29.17% above the sector average29.17% above the sector average29.17% above the sector average29.17% above the sector average29.17% above the sector average
Price Chg 3m
62.17% above the market average62.17% above the market average62.17% above the market average62.17% above the market average62.17% above the market average
70.83% above the sector average70.83% above the sector average70.83% above the sector average70.83% above the sector average70.83% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
93.96% above the market average93.96% above the market average93.96% above the market average93.96% above the market average93.96% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Momentum 20
38.32% above the market average38.32% above the market average38.32% above the market average38.32% above the market average38.32% above the market average
46.67% above the sector average46.67% above the sector average46.67% above the sector average46.67% above the sector average46.67% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
46.18% below the market average46.18% below the market average46.18% below the market average46.18% below the market average46.18% below the market average
25.71% above the sector average25.71% above the sector average25.71% above the sector average25.71% above the sector average25.71% above the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
10.96% above the market average10.96% above the market average10.96% above the market average10.96% above the market average10.96% above the market average
66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average
Forecast EPS
63.84% below the market average63.84% below the market average63.84% below the market average63.84% below the market average63.84% below the market average
75% below the sector average75% below the sector average75% below the sector average75% below the sector average75% below the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
37.87% above the market average37.87% above the market average37.87% above the market average37.87% above the market average37.87% above the market average
54.29% above the sector average54.29% above the sector average54.29% above the sector average54.29% above the sector average54.29% above the sector average
Operating Profit Loss
81.16% below the market average81.16% below the market average81.16% below the market average81.16% below the market average81.16% below the market average
41.67% below the sector average41.67% below the sector average41.67% below the sector average41.67% below the sector average41.67% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
40.75% above the market average40.75% above the market average40.75% above the market average40.75% above the market average40.75% above the market average
52.17% above the sector average52.17% above the sector average52.17% above the sector average52.17% above the sector average52.17% above the sector average
Cash
44.41% above the market average44.41% above the market average44.41% above the market average44.41% above the market average44.41% above the market average
57.45% above the sector average57.45% above the sector average57.45% above the sector average57.45% above the sector average57.45% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y Not Available

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
93.58% below the market average93.58% below the market average93.58% below the market average93.58% below the market average93.58% below the market average
86.67% below the sector average86.67% below the sector average86.67% below the sector average86.67% below the sector average86.67% below the sector average
Brokers Percent Neutral
79.82% above the market average79.82% above the market average79.82% above the market average79.82% above the market average79.82% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 64.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 64.60p
52 Week Low 29.35p
Volume 126,403
Shares Issued 540.57m
Market Cap £348.66m
Beta 0.01
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
23.92% above the market average23.92% above the market average23.92% above the market average23.92% above the market average23.92% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
84.17% above the market average84.17% above the market average84.17% above the market average84.17% above the market average84.17% above the market average
91.67% above the sector average91.67% above the sector average91.67% above the sector average91.67% above the sector average91.67% above the sector average
Income Not Available
Growth
50.9% below the market average50.9% below the market average50.9% below the market average50.9% below the market average50.9% below the market average
56.25% below the sector average56.25% below the sector average56.25% below the sector average56.25% below the sector average56.25% below the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 5
Sell 1
Strong Sell 0
Total 8
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 22-Jun-23 22-Dec-22
Paid 18-Jul-23 19-Jan-23
Amount 1.18p 0.59p

Trades for 29-Apr-2025

Time Volume / Share Price
11:38 28,839 @ 64.41p
11:35 2,265 @ 64.50p
11:35 4,378 @ 64.50p
11:33 14,755 @ 64.41p
11:32 5,074 @ 64.50p

Alliance Pharma Key Personnel

CFO Andrew Franklin
Chair Camillo Pane
CEO Nick Sedgwick

Top of Page